XML 20 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Marketable Securities
9 Months Ended
Sep. 30, 2018
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
Marketable Securities
Available-for-sale marketable securities and cash and cash equivalents as of September 30, 2018 and December 31, 2017 consist of the following (in thousands):
 
September 30, 2018
 
Amortized Cost Value
 
Gross 
Unrealized 
Gains
 
Gross 
Unrealized 
Losses
 
Fair Value
Cash and cash equivalents:
 

 
 

 
 

 
 

Cash
$
15,236

 
$

 
$

 
$
15,236

Money market funds
46,778

 

 

 
46,778

Total
$
62,014

 
$

 
$

 
$
62,014

 
 
 
 
 
 
 
 
Marketable securities:
 

 
 

 
 

 
 

Domestic corporate debt securities
$
155,346

 
$

 
$
(643
)
 
$
154,703

Agency bonds
59,981

 

 
(329
)
 
59,652

Total
$
215,327

 
$

 
$
(972
)
 
$
214,355

 
 
December 31, 2017
 
Amortized Cost Value
 
Gross 
Unrealized 
Gains
 
Gross 
Unrealized 
Losses
 
Fair Value
Cash and cash equivalents:
 

 
 

 
 

 
 

Cash
$
73,302

 
$

 
$

 
$
73,302

Money market funds
325

 

 

 
325

Domestic corporate commercial paper
44,937

 

 

 
44,937

Total
$
118,564

 
$

 
$

 
$
118,564

 
 
 
 
 
 
 
 
Marketable securities:
 

 
 

 
 

 
 

Domestic corporate debt securities
$
207,320

 
$
1

 
$
(235
)
 
$
207,086

Domestic corporate commercial paper
29,844

 

 
(7
)
 
29,837

Agency bonds
74,842

 

 
(73
)
 
74,769

Total
$
312,006

 
$
1

 
$
(315
)
 
$
311,692


There were no available-for-sale marketable securities that had been in an unrealized loss position for more than 12 months as of September 30, 2018 or December 31, 2017, respectively. There were 29 marketable securities with an aggregate fair value of $214.4 million in an unrealized loss position for less than 12 months as of September 30, 2018. There were 38 marketable securities with an aggregate fair value of $299.2 million in an unrealized loss position for less than 12 months as of December 31, 2017. The Company considered the decrease in market value for these securities to be primarily attributable to current economic conditions. As it was not more likely than not that the Company would be required to sell these securities before the recovery of their amortized cost basis, which may be at maturity, the Company did not consider these investments to be other-than-temporarily impaired as of September 30, 2018.
As of September 30, 2018, the aggregate fair value of marketable securities maturing within one year and after one year through two years was $172.1 million and $42.2 million, respectively.